In September 2023, Dawn Wilson was appointed Vice President of Research and Development. Ms. Wilson joined Anika in February 2020 following the acquisition of Arthrosurface, Inc. where she spent 16 years leading the Quality and Regulatory functions. Ms. Wilson brings over 30 years of experience in the medical device industry leading quality and regulatory, product development, as well as manufacturing engineering. Prior to this role, Ms. Wilson was VP of Quality and Regulatory with Arthrosurface Inc. and transitioned to Director of Product Development R&D following the Anika acquisition of Arthrosurface. She has also held various senior level roles in Quality Assurance with Tissuelink Medical, subsequently acquired by Medtronic, and engineering roles with several other medical device companies.
Ms. Wilson holds a B.S. in Biomedical Engineering from Boston University and an M.S. in Management Engineering from the University of Bridgeport, CT